SCHEDULE: Caligan Partners Discloses 6.4% Stake in Evolus

Caligan Partners LP and David Johnson have reported a 6.4% beneficial ownership stake in Evolus, Inc., totaling 4,138,943 shares of common stock.

Summary

• Caligan Partners LP and its Managing Partner, David Johnson, have filed an Amendment No. 1 to Schedule 13G, disclosing their beneficial ownership in Evolus, Inc.
• The reporting persons collectively own 4,138,943 shares of Evolus, Inc. common stock.
• This ownership represents 6.4% of the company's outstanding common stock.
• The percentage is calculated based on 64,685,419 shares of Common Stock outstanding as of August 1, 2025, as reported in Evolus's Form 10-Q for the quarter ended June 30, 2025.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Evolus, Inc., with the exception of activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: This is a neutral, factual report of beneficial ownership. It does not contain information that inherently indicates positive or negative sentiment about the company's performance or prospects, beyond the fact of a significant investor holding a stake.

Positives

• NA

Negatives

• NA

Risks

• The reporting persons' ownership, while stated as not for control, includes an exception for activities solely in connection with a nomination under Rule 14a-11, indicating a potential for future engagement in corporate governance through director nominations.

Future Outlook

The filing does not provide forward-looking statements or guidance from Evolus, Inc. It primarily reports a change in beneficial ownership by an investment firm.

Industry Context

This filing reflects a significant ownership position taken by an investment firm in a publicly traded company, a common occurrence in the financial markets. The mention of Rule 14a-11 suggests a potential for active shareholder engagement, which is a growing trend across various industries where institutional investors seek to influence corporate strategy or governance.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: The disclosure of a significant 6.4% stake by an investment firm, particularly with the potential for proxy access, could signal increased scrutiny or strategic input into Evolus's operations and governance. This may be viewed positively by some investors seeking active oversight or negatively by those preferring less activist involvement.

Next Steps

• NA

Key Dates

Keywords

Evolus Inc, Caligan Partners, David Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Investment Management, Shareholder Activism, Proxy Access